Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The Food and Drug Administration (FDA) has issued a Safety Communication about an ongoing review of stimulant medication used in children with attention-deficit hyperactivity disorder (ADHD) because of reports of sudden cardiac death in healthy children. The events are part of a study published in the American Journal of Psychiatry. Because of the study’s limitations, the FDA urges parents not to stop a child’s stimulant medication based on the study and to discuss concerns about the use of these medications with the health care professional who prescribed the medications.

Read the rest of this entry »